Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb dose-finding study of estradiol-progestin vaginal rings versus NuvaRing in healthy women
2012-002459-41Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of estradiol, nomegestrol, etonogestrel and etonogestrel + ethinyl estradiol in contraception (7 arms), sponsored by Merck & Co. Primary endpoint: Ovulation inhibition. Started Sep 2012; status: completed.
02
Drugs
estradiolnomegestroletonogestreletonogestrel + ethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on 2012-002459-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002459-41.